Medication discontinuation and reinitiation among Medicare part D beneficiaries taking costly medications

American Journal of Pharmacy Benefits

Volumn 3, Issue 4, 2011, Pages

  Colby, Margaret S ^a   Esposito, Dominick ^b   Goldfarb, Seth ^c   Ball, Daniel E ^d   Herrera, Vivian ^c   Conwell, Leslie J ^a   Garavaglia, Susan B ^c   Meadows, Eric S ^d   Marciniak, Martin D ^e  

^a From Mathematica Policy Research   (United States)

^b MATHEMATICA POLICY RESEARCH   (United States)

^c Medco Health Solutions   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICARE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRESCRIPTION; RETREATMENT; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; TREATMENT INDICATION; TREATMENT WITHDRAWAL;

EID: 84859756308     PISSN: 19454481     EISSN: 21642494     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hoadley J, Hargrave E, Cubanski J, Neuman T. The Medicare Part D Coverage Gap: Costs and Consequences in 2007. Washington, DC: Kaiser Family Foundation; 2008.
2. Sun SX, Lee KY, Aruru M. Examining Part D beneficiaries' medication use in the doughnut hole. Am J Pharm Benefits. 2009;1(1):19-28.
3. Zhang Y, Donohue JM, Newhouse JP, Lave JR. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff (Millwood). 2009; 28(2):w317-w325.
4. Agency for Healthcare Research and Quality. Choosing medications for adults with rheumatoid arthritis. http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=sg&DocID=85&ProcessID=14. Published 2008. Accessed February 25, 2009.
5. Bach PB. Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med. 2009;360(6):626-633.
6. Tigue CC, Fitzner KA, Alkhatib M, Schmid E, Bennett CL. The value of innovation: the economics of targeted drugs for cancer. Target Oncol. 2007;2(2): 113-119.
7. Office of Inspector General. Effect of the Part D Coverage Gap on Medicare Beneficiaries Without Financial Assistance in 2006. Washington, DC: US Dept of Health and Human Services; 2009.
8. Wolters Kluwer Health. Medicare Part D "doughnut hole" spurs seniors to drop meds. http://www.wolterskluwer.com/WK/Press/Latest+News/2006/Sep/pr_21Sept06b.htm. Published 2006. Accessed October 22, 2009.
9. Esposito D, Bagchi A, Verdier J, Bencio DS, Kim MS. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. Am J Manag Care. 2009;15(7):437-445.
10. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349-2359.
11. Joyce GF, Goldman DP, Karaca-Mandic P, Zheng Y. Pharmacy benefit caps and the chronically ill. Health Aff (Millwood). 2007;26(5):1333-1344.
12. National Cancer Institute. Tamoxifen questions and answers. http://www.cancer.gov/cancertopics/factsheet/therapy/tamoxifen. Published 2008. Accessed March 16, 2009.
13. Jordan VC. Tamoxifen treatment for breast cancer: concept to gold standard. Oncology. 1997;11(2):7-13.
14. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment [published correction appears in N Engl J Med. 2009;360(15):1579]. N Engl J Med. 2008; 358(11):1160-1174.
15. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15-25.
16. Fung V, Price M, Hsu J. Anticipating the Medicare Part D coverage gap: are beneficiaries aware of their proximity to the coverage gap? Paper presented at: International Health Economics Association 7th World Congress; July 12-15, 2009; Beijing, China.
17. Goldman D, Jena A, Lakdawalla D, Malin JL, Malkin JD, Sun E. The value of specialty oncology drugs. Wiley InterScience. http://www3.interscience.wiley.com/cgi-bin/fulltext/122667358/PDFSTART. Published October 29, 2009. Accessed November 23, 2009.
18. Kirking DM, Lee JA, Ellis JJ, Briesacher B, Mckercher PL. Patient-reported underuse of prescription medications: a comparison of nine surveys. Med Care Res Rev. 2006;63(4):427-446.
19. Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009;44(5 pt 1):1640-1661.
20. Greene J, Hibbard J, Murray JF, Teutsch SM, Berger ML. The impact of consumer-directed health plans on prescription drug use. Health Aff (Millwood). 2008;27(4):1111-1119.